Product Description
CHARMAN 375101 is designed for research on orally administered nanotherapeutics aimed at Parkinson's disease. This product addresses the challenges faced by standard therapies, particularly with transport limitations across the blood-brain barrier and hepatic metabolism. The application of nanotechnology seeks to enhance drug delivery through the oral route, leveraging nanocarriers such as nanoparticles and lipid nanoparticles. These technologies aim to optimize drug bioavailability and improve therapeutic outcomes.
Focuses on orally administered nanotherapeutics.
Designed for Parkinson's disease research.
Explores nanotechnology to improve drug delivery.
Product Highlights
This product provides a novel approach to drug delivery, enhancing research capabilities for Parkinson's disease treatments.
Product Information
Standard Information
Brand: CHARMAN
MPN: 375101
Technical Specifications
Research Focus: Parkinson's Disease
Delivery Method: Orally Administered
Nanotechnology: Utilizes nanocarriers
Product DescriptionCHARMAN 375101 is designed for research on orally administered nanotherapeutics aimed at Parkinson's disease. This product addresses the challenges faced by standard therapies, particularly with transport limitations across the blood-brain barrier and hepatic metabolism. The application of nanotechnology seeks to enhance drug delivery through the oral route, leveraging nanocarriers such as nanoparticles and lipid nanoparticles. These technologies aim to optimize drug bioavailability and improve therapeutic outcomes.
Focuses on orally administered nanotherapeutics.
Designed for Parkinson's disease research.
Explores nanotechnology to improve drug delivery.
Product HighlightsThis product provides a novel approach to drug delivery, enhancing research capabilities for Parkinson's disease treatments.Product Information
Standard Information
Brand: CHARMAN
MPN: 375101
Technical Specifications
Research Focus: Parkinson's Disease
Delivery Method: Orally Administered
Nanotechnology: Utilizes nanocarriers
Product DescriptionCHARMAN 375101 is designed for research on orally administered nanotherapeutics aimed at Parkinson's disease. This product addresses the challenges faced by standard therapies, particularly with transport limitations across the blood-brain barrier and hepatic metabolism. The application of nanotechnology seeks to enhance drug delivery through the oral route, leveraging nanocarriers such as nanoparticles and lipid nanoparticles. These technologies aim to optimize drug bioavailability and improve therapeutic outcomes.
Focuses on orally administered nanotherapeutics.
Designed for Parkinson's disease research.
Explores nanotechnology to improve drug delivery.
Product HighlightsThis product provides a novel approach to drug delivery, enhancing research capabilities for Parkinson's disease treatments.Product Information
Standard Information
Brand: CHARMAN
MPN: 375101
Technical Specifications
Research Focus: Parkinson's Disease
Delivery Method: Orally Administered
Nanotechnology: Utilizes nanocarriers
Vendor: CHARMAN
Vendor Raw: CHARMAN
Product Type: Air Purifiers
Availability Text: In Stock
Brand: CHARMAN
MPN: 375101
Research Focus: Parkinson's Disease
Delivery Method: Orally Administered
Nanotechnology: Utilizes nanocarriers
Tags: AI_Content, loc_2, Parcel
Source file: 375101 - charman-375101-orally-administered-nanotherapeutics-for-parkinsons-disease.json.json
| Brand | CHARMAN |
|---|---|
| MPN | 375101 |
| Research Focus | Parkinson's Disease |
| Delivery Method | Orally Administered |
| Nanotechnology | Utilizes nanocarriers |
| Vendor | CHARMAN |
| Vendor Raw | CHARMAN |
| SKU | 375101 |
| Tipo de producto | Air Purifiers |
| Disponibilidad | In Stock |
| Mensaje de envío | Ships Same Day if Ordered by 12 pm |
| Moneda | USD |
| Handle Shopify | charman-375101-orally-administered-nanotherapeutics-for-parkinsons-disease |
| Shopify Product ID | 9931229659442 |
| Peso | 1 lb |
| Peso gramos | 454 |
| Tags | AI_Content, loc_2, Parcel |